JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M411392200 on May 4, 2005

J. Biol. Chem., Vol. 280, Issue 28, 26216-26224, July 15, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/28/26216    most recent
M411392200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X.
Right arrow Articles by Groopman, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X.
Right arrow Articles by Groopman, J. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Kaposi's Sarcoma-associated Herpesvirus Activation of Vascular Endothelial Growth Factor Receptor 3 Alters Endothelial Function and Enhances Infection*

Xuefeng Zhang{ddagger}§, Jian Feng Wang{ddagger}, Bala Chandran¶, Kris Persaud||, Bronislaw Pytowski||, Joyce Fingeroth{ddagger}**, and Jerome E. Groopman{ddagger}{ddagger}{ddagger}

From the Divisions of {ddagger}Experimental Medicine and **Infectious Diseases, Department of Medicine and Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, the Department of Microbiology, Molecular Genetics, and Immunology, The University of Kansas Medical Center, Kansas City, Kansas 66160, and the ||Department of Molecular and Cellular Biology, ImClone Systems, New York, New York 10014

Kaposi's sarcoma-associated herpesvirus (KSHV; also known as human herpesvirus 8) is the etiologic agent of Kaposi's sarcoma, an endothelial neoplasm. This {gamma}-herpesvirus encodes for several unique proteins that alter target cell function, including the virion envelope-associated glycoprotein B (gB). Glycoprotein B has an RGD (Arg-Gly-Asp) motif at the extracellular amino terminus region and binds to the {alpha}3{beta}1 surface integrin, which enhances virus entry. We now report that gB can activate the vascular endothelial growth factor receptor 3 (VEGFR-3) on the surface of microvascular endothelial cells and trigger receptor signaling, which can modulate endothelial migration and proliferation. Furthermore, we observed that VEGFR-3 expression and activation enhance KSHV infection and participate in KSHV-mediated transformation. These functional changes in the endothelium may contribute to the pathogenesis of Kaposi's sarcoma and suggest that interventions that inhibit gB activation of VEGFR-3 could be useful in the treatment of this neoplasm.


Received for publication, October 6, 2004 , and in revised form, March 21, 2005.

* This work was supported in part by National Institutes of Health Grant 1R01 DA15008-01 and Public Health Service Grant CA 75911 (to B. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Bertlesmann Cancer Research Fellow.

{ddagger}{ddagger} To whom correspondence should be addressed: Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Inst. of Medicine, 4 Blackfan Circle, Boston, MA 02115. Tel.: 617-667-0070; Fax: 617-975-5244; E-mail: jgroopma{at}bidmc.harvard.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
M. V. Veettil, S. Sadagopan, N. Sharma-Walia, F.-Z. Wang, H. Raghu, L. Varga, and B. Chandran
Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ({alpha}V{beta}5, {alpha}V{beta}3, and {alpha}3{beta}1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection
J. Virol., December 15, 2008; 82(24): 12126 - 12144.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. A. Morris, A. S. Punjabi, and M. Lagunoff
Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells
J. Virol., September 1, 2008; 82(17): 8771 - 8779.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Q. Cai, M. Murakami, H. Si, and E. S. Robertson
A Potential {alpha}-Helix Motif in the Amino Terminus of LANA Encoded by Kaposi's Sarcoma-Associated Herpesvirus Is Critical for Nuclear Accumulation of HIF-1{alpha} in Normoxia
J. Virol., October 1, 2007; 81(19): 10413 - 10423.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. S. Sundar and T. S. Ganesan
Role of Lymphangiogenesis in Cancer
J. Clin. Oncol., September 20, 2007; 25(27): 4298 - 4307.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Zhang, J. F. Wang, G. Kunos, and J. E. Groopman
Cannabinoid Modulation of Kaposi's Sarcoma Associated Herpesvirus Infection and Transformation
Cancer Res., August 1, 2007; 67(15): 7230 - 7237.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.